METROPOLITAN LIFE INSURANCE CO/NY - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$3,193,202
+93.1%
68,923
+1.6%
0.05%
+80.0%
Q1 2019$1,653,500
+69.5%
67,822
-0.9%
0.03%
+50.0%
Q4 2018$975,498
-5.3%
68,456
+1.0%
0.02%
+11.1%
Q3 2018$1,030,134
-99.9%
67,7720.0%0.02%0.0%
Q2 2018$1,137,214,000
-45.7%
67,772
-47.2%
0.02%
-40.0%
Q1 2018$2,092,811,000
+260849.0%
128,236
+104.8%
0.03%
+172.7%
Q4 2017$802,000
-45.1%
62,618
-47.2%
0.01%
+22.2%
Q3 2017$1,460,000
+46.3%
118,685
-0.4%
0.01%
+28.6%
Q2 2017$998,000
-5.5%
119,176
+0.9%
0.01%0.0%
Q1 2017$1,056,000
+2.0%
118,155
+0.3%
0.01%0.0%
Q4 2016$1,035,000
+55.4%
117,751
+19.3%
0.01%
+40.0%
Q3 2016$666,000
+90.3%
98,718
+0.5%
0.01%
+66.7%
Q2 2016$350,000
+20.7%
98,1870.0%0.00%
+50.0%
Q1 2016$290,000
-29.3%
98,187
+1.0%
0.00%
-33.3%
Q4 2015$410,000
-7.7%
97,2600.0%0.00%0.0%
Q3 2015$444,000
-33.6%
97,260
+4.9%
0.00%
-40.0%
Q2 2015$669,000
-12.9%
92,722
-11.0%
0.01%
-16.7%
Q1 2015$768,000
+61.7%
104,197
+3.8%
0.01%
+100.0%
Q4 2014$475,000
+32.7%
100,3910.0%0.00%0.0%
Q3 2014$358,000
+1.4%
100,391
+29.7%
0.00%
+50.0%
Q2 2014$353,000
-24.2%
77,423
-22.0%
0.00%
-33.3%
Q1 2014$466,000
-6.2%
99,2520.0%0.00%0.0%
Q4 2013$497,000
-19.4%
99,2520.0%0.00%
-40.0%
Q3 2013$617,000
+39.0%
99,252
+1.6%
0.01%
+25.0%
Q2 2013$444,00097,7310.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
BVF INC/IL 9,719,589$60,456,00010.40%
KOPP INVESTMENT ADVISORS LLC 2,808,537$17,470,0006.42%
Redmile Group, LLC 3,669,593$22,825,0003.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,585,406$65,841,0003.06%
QVT Financial LP 2,878,600$17,905,0001.22%
APEX CAPITAL, LLC 2,500,000$15,550,0001.12%
FBR & Co. 113,500$706,0001.07%
Artal Group S.A. 3,000,000$18,660,0000.61%
Perimeter Capital Partners, LLC 486,478$3,026,0000.56%
Orbimed Advisors 4,831,600$30,053,0000.54%
View complete list of ARRAY BIOPHARMA INC shareholders